Micro & Small-Cap Stock Report


WEDNESDAY - OCTOBER 31, 2007..... Wall Street pulled back Tuesday as investors uneasy after a drop in consumer confidence traded cautiously ahead of the Federal Reserve's rate decision. After the Fed's half-point reduction in September, most investors expect the central bank to deliver a quarter-point cut at the conclusion of its two-day meeting on Wednesday. But inflation remains a threat. Crude oil prices fell Tuesday, but only after hitting a record a day earlier, and meanwhile, the dollar has been tumbling. So a rate cut -- much less additional decreases in the coming months -- is not a given. Some on Wall Street fear economic growth could halt if rates aren't lowered, given the troubles in housing and credit. The statement the Fed issues alongside its rate decision will be closely read for clues about future moves. "We don't think the economy's about to slip into recession. The corporate portion of the economy is still in pretty good shape," said Phil Orlando, chief equity market strategist at Federated Investors. "However, should the Fed choose not to cut anymore, and the economy continue to slip, that potentially could raise some concerns for us." Most earnings have been coming in better than expected over the past few weeks, particularly in the technology sector. But consumers, the key drivers of the economy, appear to be flagging. Following last week's news of a significant decline in existing home sales and Standard & Poor's report Tuesday of home prices sinking further, the Conference Board said its index of consumer confidence fell to its lowest level in two years in October. The index came in at 95.6, below the consensus estimate of 99.5 and down from a revised reading of 99.5 in September. The Dow Jones industrial average fell 77.79, or 0.56 percent, to 13,792.47. Broader stock indicators were mixed. The S&P 500 index fell 9.96, or 0.65 percent, to 1,531.02, while the Nasdaq composite index fell 0.73, or 0.03 percent, to 2,816.71. Treasury bond prices were little changed ahead of the Fed decision. The yield on the 10-year Treasury note, which moves inversely to its price, was at 4.38 percent, flat with late Monday.

The market remains nervous that even if the Fed decreases the target fed funds rate by a quarter-point or half-point, the move may not end up helping the credit and housing markets. It's not the price of borrowing that's deterring investors, many say; demand has waned because of worries about the quality of the underlying assets. Furthermore, the central bank must walk a narrow line between keeping investors calm and acknowledging the problems out there -- particularly for the banks and brokerages that could see more big losses if portions of the credit market, like asset-backed commercial paper, don't improve. "Providing the superficial image of stability when everybody realizes things aren't normal just doesn't work," said Axel Merk, manager of the Merk Hard Currency Fund. Some disappointing financial reports from Procter & Gamble Co. and Qwest Communications International Inc., as well as a management shake-up at Merrill Lynch & Co., gave the market little reason to buy ahead of the Fed meeting.

Merrill Lynch's chairman and chief executive, Stan O'Neal, retired Tuesday as expected after the brokerage last week posted the biggest quarterly loss in its 93-year history. But no replacement was named. Alberto Cribiore, a director since 2003, was named interim non-executive chairman. Merrill Lynch fell $1.86, or 2.8 percent, to $65.56. Procter & Gamble was the biggest loser among the 30 Dow components after cautioning that higher commodity costs will squeeze second-quarter margins. P&G fell $2.88, or 4 percent, to $68.95. Although Qwest reported a third-quarter profit jump, its shares tumbled $1.12, or 13.7 percent, to $7.06. Overall revenue dipped, and the telecommunications company provided few details about its outlook. The technology-dominated Nasdaq performed better than the other indexes, helped by ongoing strength in such bellwethers as Apple Inc., Microsoft Corp., and Google Inc. Apple rose $1.91 to $187; Microsoft rose $1, or 2.9 percent, to $35.57; and Google rose $15.54, or 2.3 percent, to $694.77. Crude oil prices retreated $3.15 to settle at $90.13 a barrel, after hitting a record on Monday above $93 a barrel. Gold also fell.

Top Stories

Amerigon Reports Solid Earnings
on Strong CCS Demand

On the eve of one of the most important Fed Reserve decisions in recent memory, the markets were mixed with the Nasdaq gaining slightly while the Dow and S&P saw small declines. Causing the mixed move was the notion that the Fed decision would have a greater impact on the Dow’s blue chip stocks and the broader overall market rather than the technology driven Nasdaq.

Earnings were still being reported in the midst of the uncertain environment, and for the most part, haven’t been as stellar as in past quarters. One name bucked that trend though, and because of the numbers, broke out to new all time highs on some fairly heavy volume.

Amerigon Inc (ARGN) develops products based on its advanced, proprietary, efficient thermoelectric (TE) technologies for a wide range of global markets and heating and cooling applications. The Company’s current principal product is its proprietary Climate Control Seat system, a solid-state, TE-based system that permits drivers and passengers of vehicles to individually and actively control the heating and cooling of their respective seats to ensure maximum year-round comfort. CCS, which is the only system of its type on the market today, uses no CFCs or other environmentally sensitive coolants. Amerigon maintains sales and technical support centers in Southern California, Detroit, Japan, Germany and England.

Before the market opened on Tuesday, the Company reported their third quarter 2007 results. Strong demand for the Company’s proprietary Climate Control Seat system drove revenues for this the third quarter and first nine months to $15.9 million and $47.2 million, respectively, up from $12.7 million and $35.6 million in last year’s third quarter and first nine months. The jump was a 25% increase from Q306 to Q307.

Net income for the third quarter was $3.1 million, or 14c per basic and 13c per diluted share, compared with net income in last year’s third quarter of $900,000, or 4c per basic and diluted share. The Company did, however, enjoy a deferred research and development (R&D) tax benefit of approximately $1.7 million following a study of its research and development activities and related expenses for the period from 1999 through 2006. They did note that they would expect to qualify for further R&D credits, but without the tax benefit during the recent quarter, net income for the third quarter was $1.3 million or 6c per adjusted basic and diluted share.

Following the announcement, shares broke out to all time highs, hitting intraday records of $22.35 before settling in the $20.00 range, up only 5.5%.

The interest could have been sparked by the GAAP numbers, which displayed the benefit and a subsequent year over year EPS increase of over 200%, but also of note was the upbeat feeling towards 2008.

President and Chief Executive Officer Daniel R. Coker noted in the press release, "We had another very good quarter, and we are continuing to have a very good year in 2007. We are achieving the goals we set out for our CCS business in 2007 and are making progress on new applications for our TE technology. As a result, our revenues are growing and expanding as we have predicted, and our bottom line is following along the same path."

Coker noted that the "take rates," which are the rates that a feature like CCS are chosen by the car buying customers, continue to reflect high acceptance, and are solid and promising. He also added that the Company is getting better penetration in Asia and Europe, a trend that should continue through at least 2008. Coker also said that the Company expects CCS revenue growth in 2008 of 30% to 40% with continued strong increases in profitability.

While the domestic economy could see a pullback causing demand for luxury items to dip, internationally, China is seeing a rising middle class which has begun to demonstrate an excess of disposable income. With a historical derived revenue mix of approximately 65% North American and 35% Asian, the Company could escape any domestic slowdown unscathed with a continuation of traction in the region.

In any event, shares have spiked extremely hard on the earnings report causing extended valuations which could limit upside for the time being. Following the close of the bell on Tuesday, the reaction of the stock even caused Roth Capital Partners to cut their rating from Buy to Hold on valuation concerns. While the name remains a solid play in the luxury area, 2008 forward price to earnings ratios of 87 are hard to justify. Investors would be wise to keep the name on the radar and look for less risky entries or names.

E-Z-EM Announces Merger with Bracco
After Revenues Curtailed by Operational Costs
E-Z-EM, Inc. (
EZEM) has announced a merger agreement with its chief competitor and long-term Italian distributor, Bracco Diagnostics Inc., to acquire all of the outstanding shares of E-Z-EM for $21.00 per share in cash. Named in Forbes Magazine’s 2007 List of Best Small Companies in America according to sustained sales and return on equity, and ranked by the Corporate Governance Quotient rating system as better than 95.5% of CGQ Universe companies and 81% of Health Care Equipment & Services companies, E-Z-EM poses a significant addition for Bracco, a U.S. subsidiary in Milan. For Fiscal Year 2006, E-ZEM posted record net sales, but earnings for its fiscal first quarter that ended September 1 fell to $645,000, a 58.7 percent drop, from nearly $1.6 million in the same period last year. Following its earnings release, however, the company cited a rise in operating expenses due to an increase of the sales for in North America, as well as legal fees for a patent lawsuit, severance costs, exchange rate fluctuations and higher research and development costs, which it believed had significantly cut into profits. But despite its promising growth from the previous year and reasons pertaining to its operating costs, a sharp decline in earnings prompted Albert Investment Strategies, the company’s second largest shareholder with a 7.5 percent stake, to suggest a possible sale of division, pay quarterly dividends, begin a share buyback program or hold off on future acquisitions. In a shareholder vote in favor of the merger, Bracco’s Aquisition of E-Z-EM gives the company an enlarged product porfolio, which include E-Z-EM’s widely distributed forumulations for CT Imaging, X-Ray Fluoroscopy, Virtual Colonoscopy, accessory medical devices, Gastroenterology, and Healthcare Decontainments. As a result of this transaction, E-Z-EM topped its 52 week high, at $20.51 in morning trading. The offer price represents an approximate 32% premium over the 10-day average closing price per share for E-Z-EM as of October 29, 2007. On a fully diluted basis, the total transaction is valued at approximately $241M. E-Z-EM has no debt outstanding and $44M in cash, cash equivalents and marketable securities. This transaction represents the culmination of a comprehensive strategic alternatives process conducted by the E-Z-EM Board of Directors over the past year to identify the best alternative to create value for E-Z-EM’s shareholders. The transaction is currently expected to close in early 2008.

Radyne Revenues Get $13.6M
Boost by Several Orders in October
Radyne Corporation’s (
RADN) October has been good thus far. In press releases during the course of the month, the Company has announced several orders valued at almost $14 million, a large portion of which coming from one of Radyne’s business units, Xicom Technology. Supplier of high power amplifiers for the commercial and military Satcom market, Xicom garnered an $8 million chunk of the total in two orders for millimeter-wave (Ka and Q-band) power amplifiers. Used in military terminals, most of the amplifiers will be used for uplinking with the U.S. Air Force’s Wideband Global System constellation of satellites. In the week prior, Radyne itself received 2 separate direct orders for its satellite communications ground equipment. The Company announced a major military communications integrator had ordered modems in support of the Ground Multi-band Terminal (GMT) program, and two other firms had placed orders for the Company’s TM-20 high capacity troposcatter modem. The beginning of the month began with an order from a telecommunications operator in North Africa. And although Xicom has received most of the recent publicity, Radyne has two other business units as well, AeroAstro, Inc. and Tiernan. According to the Company’s website, AeroAstro designs and builds spacecraft equipment, including microsatellites and related technologies. Tiernan supplies video / audio compression and transmission equipment for the broadcasting community. Radyne has posted TTM revenues of $132.4 million with a net margin of 8.22%. The Company is expected to report Q3 earnings after the market closes next Monday, and analysts are expecting $0.21 – $0.17 per share.

Bradley Pharmaceuticals Shareholders
Offered $346M from Nycomed at $20 Per Share
Nycomed announced the entry into a definitive agreement to acquire Bradley Pharmaceuticals, Inc. (
BDY) to build on its PharmaDerm division and enhance its platform for acquisition, in-licensing and co-promotion. The transaction is expected to close in the first quarter of 2008. Nycomed plans to leverage its manufacturing and distribution capabilities to support the Bradley products line, improve customer service and optimise the cost structure. In addition, Nycomed will leverage the combined sales and marketing capabilities to enhance both the Bradley and Nycomed product lines. Nycomed will offer $20.00 per share in cash, or an equity purchase price of $346M to Bradley’s shareholders. The acquisition will be financed through strong generation of excess cash in 2007, equity commitment by current investors and by utilization of available credit facilities. The acquisition is expected to be completed in the first quarter of 2008, during which Nycomed intends to delist Bradley.

Today's Headlines

SIGNS AS POINT-OF-SALE PROVIDER: Radiant Systems, Inc. (RADS) has announced an agreement with Texas Roadhouse, Inc. (TXRH) to be its exclusive point of sale provider. Radiant will provide P1220 and P1520 point-of-sale terminals to the chain’s 274 restaurants. Operating in 44 states nationwide, Texas Roadhouse currently uses Radiant’s Aloha TableService point of sale and MenuLink labor and inventory solutions. Radiant will also provide a comprehensive hardware field maintenance program that is designed to provide faster return to service and valuable long-term benefits resulting in unsurpassed system uptime.

INITIATES CLINICAL STUDY: Enzon Pharmaceuticals, Inc. (ENZN) announced the initiation of clinical study of the HIF-1 alpha antagonist (EZN-2968) evaluating an additional dosing schedule. The open-label, non-randomized Phase 1 study is designed to evaluate the safety, tolerability, and pharmacokinetics of the HIF-1 alpha antagonist in a daily for 5 days schedule in approximately 30 patients with advanced solid tumors or lymphoma. Hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a key regulator of a large number of genes important in cancer biology. High expression of HIF-1 alpha is strongly correlated with poor prognosis and resistance to therapy. Therefore, drugs that inhibit HIF-1 alpha are expected to block multiple mechanisms that control cancer progression.

SELECTS CONVERTERS PRODUCTS AND PROCESSING ENGINE: DataDirect Technologies and an operating company of Progress Software Corporation (PRGS) announced that Document Sciences Corporation (DOCX) has embedded DataDirect XML Converters products and DataDirect XQuery processing engine into its next-generation xPression 3 software suite. More than 600 organizations worldwide use Document Sciences’ technologies to optimize the customer experience, reduce costs and increase competitiveness.

FORMS STRATEGIC AGREEMENT: NYFIX, Inc. (NYFX) and Citi (C) announced a strategic agreement under which NYFIX and Citi will jointly offer NYFIX Fusion Order Management System clients a transition arrangement to the Lava ColorPalette(R) OMS. All of the transitioned clients, as well as existing Lava ColorPalette OMS clients, will have access to NYFIX’s full suite of electronic trading services, including the NYFIX Marketplace(TM), NEXAS(R) algorithms and the NYFIX Millennium ATS, through an integrated solution with Lava ColorPalette. ColorPalette clients will continue to have access to the Citi Electronic Execution Service products. The decision to exit its Fusion OMS business enables NYFIX to devote more resources to clients of its FIXTrader(R) desktop trading solution and its Marketplace and Transactions businesses, which are more closely aligned with NYFIX’s strategy to facilitate the trading process by providing robust electronic trading tools and access to multiple liquidity sources.

SIGNS DEFINITIVE AGREEMENT FOR ACQUISITION: Crdentia Corp. (CRDT) announced that it has signed a definitive agreement to acquire Medical People Healthcare Services Inc. Approximately 65% of MPHS’s revenues are from healthcare staffing in the nursing home segment, with the remaining revenues from services to local hospitals and other healthcare facilities. Terms of the acquisition include $750,000 in cash and $500,000 in a 3-year note payable. Crdentia expects this acquisition to close in the next two weeks.

IMPLEMENTS A NUMBER OF COST-REDUCTION MEASURES: In an 8k filing dated October 30, 2007, it was reported by Maritech Inc. (MZT) that Matritech had implemented a number of cost-reduction measures including selective curtailment of expenditures and decrease of staff in regulatory affairs, marketing and administration. Matritech has also terminated most of its research and development staff and is no longer pursuing further development or submission on any of its research and development programs.

ENTERS $16M AGREEMENT: Secured Digital Applications, Inc. (SDGL) have entered into an agreement with Collier Consulting Inc. for the sale, marketing and administration of its EyStar GPS Personal and Vehicle Tracker to automotive dealers across the United States through National Automotive Experts. The anticipated revenue from the contract is $16M with the first delivery of the product expected in the first quarter of 2008. Ron Collier, Vice President of Collier Consulting stated, "We believe that this is a major step in introducing Secured Digital’s technology and products to this industry and are very excited about the revenue potential that these products possess."

ANNOUNCES INTEGRATION FOR FIRST HARDWARE ENCODING APPLIANCE: On2 Technologies Inc. (ONT) and RipCode, Inc. announced that RipCode has integrated the On2 VP6 codec used in Adobe Flash Player 8 and 9, for the industry’s first hardware accelerated 2-pass encoding appliance for VP6 recently launched by RipCode. As a result of this agreement, On2 VP6 based services will be able to deliver transcoding for video on demand, enabling broadcasters, syndicators, or user generated video sites to eliminate storage of multiple file formats and deliver files from their entire video library for any application.

 

 

What did you think of this article?




Trackbacks
  • Trackbacks are closed for this entry.
Comments
  • No comments exist for this entry.
Leave a comment

Submitted comments will be subject to moderation before being displayed.

 Enter the above security code (required)

 Name

 Email (will not be published)

 Website

Your comment is 0 characters limited to 3000 characters.